Press release
Emerging Sub-Segments Transforming the Bioresorbable Medical Material Market Landscape
Bioresorbable Medical Material Market
Projected Growth Trajectory of the Bioresorbable Medical Material Market
The bioresorbable medical material market is set to grow substantially over the coming years, reaching a valuation of $2.77 billion by 2030. This expansion corresponds to a compound annual growth rate (CAGR) of 10.1% during the forecast period. Driving this growth is the increasing adoption of regenerative medicine therapies, a rising preference for next-generation implant materials, and the widening use of personalized medical devices. Additional factors include growing investments in tissue engineering technologies and a stronger focus on minimizing the need for secondary surgeries. Key trends shaping the market involve the rising use of bioresorbable polymer implants, temporary medical implants, advanced tissue engineering scaffolds, drug-eluting bioresorbable devices, and materials engineered for controlled degradation.
Download a free sample of the bioresorbable medical material market report:
https://www.thebusinessresearchcompany.com/report/bioresorbable-medical-material-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
Leading Corporations Influencing the Bioresorbable Medical Material Market
Several prominent companies are shaping the bioresorbable medical material landscape, including Johnson & Johnson, Abbott Laboratories, Medtronic PLC, Kureha Corporation, and Evonik Industries AG. Other significant players include Stryker Corporation, Toray Industries Inc., Mitsui Chemicals Inc., Arkema S.A., Royal DSM N.V., Zimmer Biomet Holdings Inc., Ashland Global Holdings Inc., and Corbion N.V. Additional noteworthy firms are Zeus Industrial Products Inc., Unitika Ltd., Danimer Scientific, Synbra Technology, KLS Martin Group, Durect Corporation, Putnam Plastics Corporation, Zhejiang Haizheng Biomaterials Co. Ltd., NatureWorks LLC, Foster Corporation, Poly-Med Inc., Futerro S.A., and TotalEnergies Corbion B.V.
Strategic Market Moves Highlighting Company Growth
In April 2024, ProMed Pharma, a US-based contract manufacturer specializing in polymer-based drug-releasing dosage forms and combination device components, acquired SpineThera for an undisclosed sum. This strategic acquisition aims to bolster ProMed Pharma's manufacturing expertise, broaden its product portfolio, and support innovative drug development initiatives. SpineThera, a clinical-stage pharmaceutical company also based in the US, focuses on cutting-edge injectable drugs using its proprietary micro-suspension platform technology.
The bioresorbable medical material market is on the brink of significant expansion as advancements in medical technology and personalized healthcare continue to accelerate. This sector is attracting considerable attention due to its innovative applications in regenerative medicine and implantable devices, promising improved patient outcomes and reduced surgical interventions. Let's explore the anticipated growth, key players, emerging trends, and market segmentation in this dynamic industry.
Projected Growth Trajectory of the Bioresorbable Medical Material Market
The bioresorbable medical material market is set to grow substantially over the coming years, reaching a valuation of $2.77 billion by 2030. This expansion corresponds to a compound annual growth rate (CAGR) of 10.1% during the forecast period. Driving this growth is the increasing adoption of regenerative medicine therapies, a rising preference for next-generation implant materials, and the widening use of personalized medical devices. Additional factors include growing investments in tissue engineering technologies and a stronger focus on minimizing the need for secondary surgeries. Key trends shaping the market involve the rising use of bioresorbable polymer implants, temporary medical implants, advanced tissue engineering scaffolds, drug-eluting bioresorbable devices, and materials engineered for controlled degradation.
Download a free sample of the bioresorbable medical material market report:
https://www.thebusinessresearchcompany.com/report/bioresorbable-medical-material-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
Leading Corporations Influencing the Bioresorbable Medical Material Market
Several prominent companies are shaping the bioresorbable medical material landscape, including Johnson & Johnson, Abbott Laboratories, Medtronic PLC, Kureha Corporation, and Evonik Industries AG. Other significant players include Stryker Corporation, Toray Industries Inc., Mitsui Chemicals Inc., Arkema S.A., Royal DSM N.V., Zimmer Biomet Holdings Inc., Ashland Global Holdings Inc., and Corbion N.V. Additional noteworthy firms are Zeus Industrial Products Inc., Unitika Ltd., Danimer Scientific, Synbra Technology, KLS Martin Group, Durect Corporation, Putnam Plastics Corporation, Zhejiang Haizheng Biomaterials Co. Ltd., NatureWorks LLC, Foster Corporation, Poly-Med Inc., Futerro S.A., and TotalEnergies Corbion B.V.
Strategic Market Moves Highlighting Company Growth
In April 2024, ProMed Pharma, a US-based contract manufacturer specializing in polymer-based drug-releasing dosage forms and combination device components, acquired SpineThera for an undisclosed sum. This strategic acquisition aims to bolster ProMed Pharma's manufacturing expertise, broaden its product portfolio, and support innovative drug development initiatives. SpineThera, a clinical-stage pharmaceutical company also based in the US, focuses on cutting-edge injectable drugs using its proprietary micro-suspension platform technology.
Emerging Trends Fuelling Growth in the Bioresorbable Medical Material Industry
The bioresorbable medical material sector is witnessing innovation through the integration of customizable technologies designed to enhance patient treatment. One notable advancement is the development of chemotherapy infusion pumps offering adjustable infusion rates for multiple drugs, facilitating tailored and precise treatment regimens. This technology supports healthcare providers in optimizing chemotherapy delivery based on individual patient needs.
An Example of Innovation in Chemotherapy Infusion Technology
For instance, in May 2023, Mindray, a China-based medical device and solution provider, launched the 'Rhythm Dose' infusion mode within its latest BeneFusion i/u infusion pump series. This feature is specifically engineered to improve chemotherapy drug delivery, allowing continuous intravenous infusions of multiple chemotherapy agents at varying rates. Such innovations enhance the potential for personalized care in cancer treatment.
Market Segmentation Highlighting the Largest Share in Bioresorbable Medical Materials
The bioresorbable medical material market is categorized into several key segments that define its structure and application areas:
1) By Type: Polylactic Acid (PLA), Polyglycolic Acid (PGA), Polysaccharides, Polycaprolactone (PCL), Poly Lactic-Co-Glycolic Acid (PLGA)
2) By Application: Drug Delivery, Orthopedics, Other Applications
3) By End-User: Hospitals and Clinics, Ambulatory Surgical Centers, Research Institutes, Other End-Users
Further Subdivisions Within the Type Segment
Each material type contains specific subcategories, such as:
- Polylactic Acid (PLA): Low Molecular Weight PLA, High Molecular Weight PLA, PLA Blends
- Polyglycolic Acid (PGA): Homopolymer PGA, Copolymer PGA
- Polysaccharides: Chitosan, Alginate, Hyaluronic Acid Derivatives
- Polycaprolactone (PCL): Standard PCL, PCL Copolymers
- Poly Lactic-Co-Glycolic Acid (PLGA): 50:50 PLGA, 75:25 PLGA
This detailed segmentation provides a comprehensive understanding of the bioresorbable medical material market's composition and highlights the diversity of products and applications driving its growth through 2030.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Emerging Sub-Segments Transforming the Bioresorbable Medical Material Market Landscape here
News-ID: 4461538 • Views: …
More Releases from The Business Research Company
Competitive Analysis: Leading Companies and New Entrants in the Calciphylaxis Ma …
The calciphylaxis market is gaining increasing attention due to advancements in treatment strategies and growing research efforts. This sector is expected to experience significant expansion driven by innovations in diagnosis, therapy, and patient care. Below, we examine the market's anticipated growth, key players, emerging trends, and crucial segments shaping its future.
Projected Calciphylaxis Market Size by 2030
The calciphylaxis market is forecasted to expand substantially, reaching a value of $5.55 billion…
Future Outlook: Key Trends Shaping the Bronchitis Treatment Market up to 2030
The bronchitis treatment market is set to experience notable expansion over the coming years, driven by advancements in respiratory care and a growing patient base. This report explores the market's anticipated growth, key players shaping the industry, evolving trends, and important segmentation details that define the marketplace landscape through 2030.
Forecasting the Bronchitis Treatment Market Size through 2030
The bronchitis treatment market is projected to grow significantly, reaching a valuation of…
Emerging Sub-Segments Transforming the Brain Artificial Intelligence (AI)-Assist …
The brain artificial intelligence (AI)-assisted diagnosis solution market is set to experience remarkable growth in the coming years as the healthcare industry increasingly embraces AI technologies for neurological care. This sector's expansion is propelled by advancements in diagnostic accuracy and early detection tools that leverage AI, creating promising opportunities for innovation and investment. Let's delve into the latest market size projections, key players, emerging trends, and important market segments shaping…
Top Players and Competitive Overview in the Bone Metabolism Tests Market
The bone metabolism tests market is poised for significant expansion in the coming years, driven by a combination of demographic shifts and technological advancements. As awareness about bone health increases and personalized medical approaches become more prevalent, this sector is set to experience substantial growth. Let's explore the current market size, key players, emerging trends, and the main segments shaping this industry's future.
Projected Market Size and Growth Trajectory of the…
More Releases for Corporation
Endotherapy Devices Market Key Players: Hoya Corporation, Olympus Corporation, S …
A fresh report titled “Endotherapy Devices Market” has been presented by KD market insights. It evaluates the key market trends, advantages, and factors that are pushing the overall growth of the market. The report also analyzes the different segments along with major geographies that have more demand for Endotherapy Devices Market. The competition analysis is also a major part of the report.
The global endotherapy devices market is projected to reach…
Digital Living Room Market 2017-2025 | Samsung Corporation, Sharp Corporation, B …
Global Digital Living Room Market: Snapshot
The living room gadgets in the early 1980s were predominantly televisions. Today, living rooms have evolved into a place with a number of devices thanks to inventions and evolution of the consumer electronics industry. Following this, researchers are focused on bridging the gaps between different devices in the living room by means of connected living rooms. This involves connecting the array of primary and secondary…
Global Healthcare Clinical Analytics Market to 2022| IBM Corporation, Cerner Cor …
Albany, NY, 3rd December : Recent research and the current scenario as well as future market potential of "Global Market Study on Healthcare Clinical Analytics: North America to be the Most Lucrative Market During the Assessment Period (2017 - 2022)" globally.
Introduction
Persistence Market Research delivers yet another unbiased, comprehensive and insightful report titled ‘Healthcare Clinical Analytics Market: Global Industry Analysis (2012-2016) and Forecast (2017-2022)’.
Get PDF for more Professional and Technical insights…
Endotherapy Devices Market Key Players : Hoya Corporation, Olympus Corporation, …
Endoscopy Devices Market is performed to examine abdominal pain, ulcers, digestive tract bleeding, and abnormal growths in the colon and other abdominal & gastrointestinal (GI) conditions. The minimally invasiveness of this procedure with fewer post operation complications makes it one of the most preferred and sought-after procedures in diagnostics and surgeries. The global endotherapy devices market is projected reach $5,015 million by 2024 from $3,369.0 million in 2017, growing at…
Endoscopy Devices Market Share with Olympus Corporation, HOYA Corporation, Fujif …
Endoscopy Devices Market Report, published by Allied Market Research, forecasts that the global market is expected to garner $40,854 million by 2022 from $27,273 million in 2015, registering a CAGR of 5.7% during the period 2016 to 2022. The flexible endoscopes are expected to dominate the global endoscopy devices market. North America is projected to continue its lead, accounting for more than one-third share of the global endoscopy devices market…
Digital Living Room Market 2017 - 2025 : Sharp Corporation, BenQ Corporation, So …
Global Digital Living Room Market: Snapshot
The living room gadgets in the early 1980s were predominantly televisions. Today, living rooms have evolved into a place with a number of devices thanks to inventions and evolution of the consumer electronics industry. Following this, researchers are focused on bridging the gaps between different devices in the living room by means of connected living rooms. This involves connecting the array of primary and secondary…
